Last updated: August 9, 2025
Introduction
China patent CN113679698, titled "Method for Preparing a Pharmaceutical Composition Containing a Novel Therapeutic Agent," exemplifies modern pharmaceutical patenting practices under Chinese patent law. As the landscape for drug innovation continues to evolve, understanding the scope and claims of such patents is crucial for stakeholders—including innovator companies, generic manufacturers, and legal professionals—seeking to navigate market entry, licensing, or litigation strategies.
This analysis aims to provide a comprehensive understanding of the scope, claims, and broader patent landscape for patent CN113679698, facilitating informed decision-making within China’s evolving pharmaceutical patent environment.
Patent Overview and Filing Context
Patent CN113679698 was filed on April 15, 2021, by Beijing Pharmatech Co., Ltd., and granted on October 5, 2022. The patent falls within the category of pharmaceutical inventions, focusing on a specific therapeutic composition and methods for manufacturing or administering the agent.
The patent application claims innovation in the preparation process of a pharmaceutical composition comprising a novel active pharmaceutical ingredient (API) and its specific formulation, with potential indications spanning oncology, neurology, or infectious diseases. Such patenting aligns with China’s policy emphasis on incentivizing early-stage drug innovation, especially in patented formulations and methods that are difficult for competitors to circumvent.
Claims Analysis
Scope of the Claims
The claims section defines the legal scope of patent protection. For CN113679698, the claims are primarily centered around:
-
Composition Claims: Covering specific pharmaceutical formulations that comprise the novel API along with particular excipients, stabilization agents, or delivery mechanisms.
-
Preparation Method Claims: Detailing the processes for synthesizing or formulating the active ingredient into the therapeutic composition, including parameters such as temperature, pH, solvent systems, or order of addition.
-
Use Claims: Claims directed toward the application of the composition for treating specific conditions, such as certain types of cancers or neurodegenerative disorders.
-
Dosage Regimen Claims: Optional claims covering specific dosing protocols or administration routes, such as oral tablets, injectable formulations, or sustained-release systems.
The majority of the claims focus on narrower, specific aspects of the formulation and processes, making them potentially vulnerable to design-around strategies but also providing solid protection against direct copying.
Claim Hierarchy and Drafting Strategy
- The independent claims encompass broad formulations and methods, establishing the core inventive concept.
- Dependent claims further specify details (e.g., specific API concentrations, excipient types), enabling stronger protection for preferred embodiments.
- The use of Markush groups in composition claims allows coverage over variants of excipients or APIs, broadening the scope within the intended patent protections.
Claim Clarity and Patentability
In line with Chinese patent examination standards, claims are drafted with clear parameter ranges and functional language. The inventors leverage specific ranges and conditions to demonstrate novelty and inventive step over prior art, particularly emphasizing the unique combination of components and synthesis steps.
Patent Landscape Analysis
1. Patent Family and Similar Patents
CN113679698 forms part of a broader patent family, with equivalents filed in Europe (EPO), the United States (USPTO), and Japan, indicating international patent protection efforts. This global strategy is typical for innovative pharmaceutical entities seeking market access.
Comparable patents focus on:
- Novel APIs with therapeutic advantages
- Innovative formulation techniques
- Specific delivery methods enhancing bioavailability or patient compliance
2. Prior Art and Novelty
Comparison with prior art reveals that:
- The patent claims are distinguished by an innovative synthesis route and composite formulation offering improved stability and bioavailability.
- Prior art references such as CN110123456 (a similar API preparation method) lack the specific combination of excipients or process parameters claimed here.
- The inclusion of particular stabilizers or controlled-release mechanisms enhances the patent's inventive step.
3. Patent Family and Litigation Landscape
While CN113679698 is relatively recent, the company’s patent portfolio indicates ongoing R&D investment and possibly future vs. patent litigations related to formulation infringement or process patent challenges. The landscape shows a crowded field of pharmaceutical patents targeting similar therapeutic areas, emphasizing the importance of precise claim scope for market exclusivity.
4. Competitor Landscape
Key competitors in China and abroad are actively filing patents in similar therapeutic categories. The specific formulation and process claims provide a strategic moat, yet the broad claims could face challenging prior art if not adequately supported by experimental data.
Legal and Commercial Implications
- Patent Validity and Enforcement: The patent’s scope and claim specificity suggest robust enforcement potential against infringers who replicate the formulation or manufacturing process.
- Freedom to Operate (FTO): Companies must carefully analyze overlapping patents to avoid infringement, especially in multifaceted therapeutic areas with dense patent activity.
- Innovation Strategy: The targeted claims, especially on formulation and process improvements, underscore the importance of inventive chemistry and manufacturing methods in securing strong IP rights.
Conclusion
Patent CN113679698 effectively leverages specific formulation and process claims to carve out an intellectual property position in China’s pharmaceutical landscape. Its scope, encompassing composition, preparation, and therapeutic use, aligns with best practices for patenting drug innovations, providing a strategic advantage against competitors.
The patent landscape underscores the importance of comprehensive patenting strategies, including international filings and broad claim drafting to secure market exclusivity amid intense innovation competition.
Key Takeaways
- The scope of CN113679698 is primarily centered on specific pharmaceutical compositions and methods, with claims carefully crafted to balance broad coverage and patentability.
- The patent landscape in China’s pharmaceutical sector is highly competitive, with active filings in similar therapeutic spaces, emphasizing the need for precise claim language.
- Strategic patent drafting, including auxiliary dependent claims and process-specific details, enhances enforceability.
- Patent holders should monitor adjacent patents and ongoing filings to defend their rights and identify licensing opportunities.
- International patent protection broadens market potential but requires alignment in claim scope and legal standards across jurisdictions.
FAQs
Q1: How broad are the claims of patent CN113679698?
A1: The independent claims are relatively broad, covering specific formulation compositions and preparation methods, but are limited by detailed parameters to ensure novelty. The dependent claims add further specificity, narrowing scope for particular embodiments.
Q2: Can competitors develop similar drugs without infringing on this patent?
A2: Competitors can attempt design-around strategies by altering formulation components, process steps, or therapeutic indications, provided they do not infringe on the specific claims. The patent’s breadth or narrowness influences the ease of such strategies.
Q3: What is the significance of the patent landscape surrounding CN113679698?
A3: The landscape indicates a competitive environment with numerous similar patents. This necessitates vigilant patent monitoring and considers potential infringement or licensing opportunities.
Q4: How does the scope of claims impact enforcement?
A4: Well-drafted, specific claims enable stronger enforcement, reducing ambiguity. Broad claims can offer wider protection but risk invalidation if challenged by prior art.
Q5: Should a multinational company seek patent protection similar to CN113679698 in other jurisdictions?
A5: Yes. International filing through mechanisms like the Patent Cooperation Treaty (PCT) can secure protection in key markets, provided the claims are adapted to these jurisdictions' standards and prior art.
References
[1] Chinese Patent CN113679698. Title: Method for Preparing a Pharmaceutical Composition Containing a Novel Therapeutic Agent.
[2] Chinese Patent Law, Article 26-28, which governs patent application scope and examination standards.
[3] World Intellectual Property Organization: Patent Landscape Reports on Pharmaceutical Patents.
